SCHEMBL6662611

SCHEMBL6662611

CN(Cl)CC(=O)c1ccc(O)c(O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 4/20 0.47
▸ CA1 P00915 4/20 0.47
▸ CA2 P00918 4/20 0.47
▸ CA7 P43166 4/20 0.47
▸ CA9 Q16790 4/20 0.47
▸ CA14 Q9ULX7 4/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ GAA P10253 2/20 0.47
▸ POLB P06746 2/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ MAPT P10636 1/20 0.47
▸ CA4 P22748 1/20 0.47
▸ CA6 P23280 1/20 0.47
▸ PTGS2 P35354 1/20 0.47
▸ PLAA Q9Y263 6/20 0.46
▸ DBH P09172 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ XDH P47989 1/20 0.46
▸ ALPG P10696 9/20 0.45
▸ ALPL P05186 7/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30309743 0.85 KDM4E (0.53) CA12CA1CA2CA7CA9
SCHEMBL421462 0.85 KDM4E (0.53) CA12CA1CA2CA7CA9
SCHEMBL22763940 0.81 CA12 (0.46) CA12CA1CA2CA7CA9
SCHEMBL21462661 0.81 CA12 (0.50) CA12CA1CA2CA7CA9
SCHEMBL9768140 0.77 ALPG (0.43) CA12CA1CA2CA7CA9
SCHEMBL26491267 0.76 PLAA (0.41) CA12CA1CA2CA7CA9
SCHEMBL29389757 0.75 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL16010437 0.75 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL2991009 0.75 CA12 (0.58) CA12CA1CA2CA7CA9
SCHEMBL30389755 0.75 CA12 (0.58) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119707710-A Norepinephrine external Process for preparing racemate 蚌埠丰原医药科技发展有限公司 2025-03-28 — — CN claimed
CN-119263998-A Production method of adrenalone hydrochloride capable of improving yield 蚌埠丰原涂山制药有限公司 2025-01-07 — — CN claimed
CN-116559325-A Separation detection method for related substances in adrenal color hydrazone 江苏亚邦爱普森药业有限公司 2023-08-08 — — CN claimed
US-20230105993-A1 RAPID POLYMERIZED CATECHOL BASED SURFACTANT ASSISTED INFILTRATION OF SOLID OXIDE ELECTROCHEMICAL CELL INFILTRATION USING SPRAYING METHOD U.S. DEPARTMENT OF ENERGY 2023-04-06 — — US claimed
CN-108047121-B Production process of adrenal color hydrazone 江苏慈星药业有限公司 2021-11-12 — — CN claimed
CN-108047121-A A kind of production technology of Adenaron 江苏慈星药业有限公司 2018-05-18 — — CN claimed
US-9964552-B2 Mass spectrometric identification and/or quantitation of catecholamines using aminopyrazoles DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) 2018-05-08 — — US claimed
US-20160305969-A1 MASS SPECTROMETRIC IDENTIFICATION AND/OR QUANTITATION OF CATECHOLAMINES USING AMINOPYRAZOLES DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) 2016-10-20 — — US claimed
EP-3063540-A1 MASS SPECTROMETRIC IDENTIFICATION AND/OR QUANTITATION OF CATECHOLAMINES USING AMINOPYRAZOLES DH Technologies Development PTE. Ltd. (SG) 2016-09-07 — — EP claimed
CN-105659078-A Mass spectrometric identification and/or quantitation of catecholamines using aminopyrazoles DH科技发展私人贸易有限公司 2016-06-08 — — CN claimed
CN-103553942-B A kind of preparation method of phenylephrine hydrochloride impurity WUHAN WUYAO TECHNOLOGY CO., LTD. (CN) 2015-11-18 — — CN claimed
WO-2015063563-A1 MASS SPECTROMETRIC IDENTIFICATION AND/OR QUANTITATION OF CATECHOLAMINES USING AMINOPYRAZOLES DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) 2015-05-07 — — WO claimed
CN-103553942-A Preparation method of phenylephrine hydrochloride impurity WUHAN WUYAO SCIENCE & TECHNOLOGY CO LTD 2014-02-05 — — CN claimed
CN-119707710-A Norepinephrine external Process for preparing racemate 蚌埠丰原医药科技发展有限公司 2025-03-28 — — CN disclosed
WO-2025059259-A1 NEW PROCESS FOR PHENYLEPHRINE AND SALBUTAMOL AND RELATED COMPOUNDS VIA ASYMETRIC TRANSFER HYDROGENATION OF UNPROTECTED AMINO KETONES VIRGINIA COMMONWEALTH UNIVERSITY (US) 2025-03-20 — — WO disclosed
CN-118255674-B Method for preparing isoprenaline hydrochloride 北京均大检测科技有限公司 2025-02-11 — — CN disclosed
US-4937360-A N-substituted amide derivatives useful for treating liver diseases TAISHO PHARMACEUTICAL CO., LTD. (JP) 1990-06-26 — — US disclosed
EP-0350251-A2 N-Substituted amide derivatives TAISHO PHARMACEUTICAL CO. LTD (JP) 1990-01-10 — — EP disclosed
US-4594356-A Topical administering an adrenalone derivative KEY PHARMACEUTICALS, INC. (US) 1986-06-10 — — US disclosed
US-4035405-A Novel synthesis for preparing the hydrochloride salt of selected catecholamine derivatives INTERX RESEARCH CORPORATION (US) 1977-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160305969-A1 MASS SPECTROMETRIC IDENTIFICATION AND/OR QUANTITATION OF CATECHOLAMINES USING AMINOPYRAZOLES AADAT, AASDHPPT, AANAT CA12 2173/4885CA1 2305/4885CA2 2444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback